Patents by Inventor Jiri HOFMANN

Jiri HOFMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND USES THEREOF
    Publication number: 20230092490
    Abstract: Pharmaceutical compositions comprising dasatinib anhydrous provide an improved, pH-independent dissolution profile compared with pharmaceutical compositions comprising dasatinib monohydrate. Thus, pharmaceutical compositions comprising dasatinib anhydrous can be used in the treatment of chronic myelogenous leukaemia (CML) and/or Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL), especially in subjects having an increased gastric pH and/or in subjects being co-administered with a gastric acid reducing agent.
    Type: Application
    Filed: March 5, 2021
    Publication date: March 23, 2023
    Applicant: ZENTIVA K.S.
    Inventors: Gregor SEDMAK, Martin NOVAK, Ales BARTUNEK, Jiri HOFMANN